OTCM
CLSH
Market cap6mUSD
Jul 09, Last price
0.04USD
1D
0.00%
1Q
24.31%
Jan 2017
-97.43%
IPO
-99.10%
Name
CLS Holdings USA Inc
Chart & Performance
Profile
CLS Holdings USA, Inc., a diversified cannabis company, focuses on the extraction and conversion of cannabinoids in the United States. It extracts cannabinoids from the cannabis plants and converts into concentrates, such as oils, waxes, edibles, and shatters. The company also sells organic medical cannabis to licensed retailers; recreational marijuana cannabis products to licensed distributors and retailers; extraction products, such as oils and waxes derived from in-house cannabis production; and offers processing and extraction services for licensed medical cannabis cultivators, as well as cannabis strains in the form of vegetative cuttings to licensed medical cannabis cultivators. In addition, it provides consulting services to cannabis-related businesses comprising growers, dispensaries, and laboratories; and toll processing services. The company offers its products under Oasis Cannabis and City Trees brand names. Its concentrates are used for pharmaceutical and other purposes. CLS Holdings USA, Inc. was founded in 2014 and is based in Miami, Florida.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2024‑05 | 2023‑05 | 2022‑05 | 2021‑05 | 2020‑05 | 2019‑05 | 2018‑05 | 2017‑05 | 2016‑05 | |
Income | |||||||||
Revenues | 19,961 -13.71% | 23,134 2.08% | |||||||
Cost of revenue | 12,527 | 14,569 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 7,434 | 8,565 | |||||||
NOPBT Margin | 37.24% | 37.02% | |||||||
Operating Taxes | 2,147 | 2,221 | |||||||
Tax Rate | 28.89% | 25.93% | |||||||
NOPAT | 5,286 | 6,344 | |||||||
Net income | (4,488) -67.48% | (13,800) 465.47% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 2,509 | 6,225 | |||||||
Long-term debt | 8,563 | 9,736 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | 10,473 | 14,963 | |||||||
Cash flow | |||||||||
Cash from operating activities | 809 | (230) | |||||||
CAPEX | (148) | (152) | |||||||
Cash from investing activities | (148) | (108) | |||||||
Cash from financing activities | (1,059) | (1,215) | |||||||
FCF | 6,172 | 7,671 | |||||||
Balance | |||||||||
Cash | 600 | 998 | |||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | (114,428) | (109,948) | |||||||
Invested Capital | 110,634 | 109,903 | |||||||
ROIC | 4.79% | 6.07% | |||||||
ROCE | |||||||||
EV | |||||||||
Common stock shares outstanding | 98,862 | 60,655 | |||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | 8,264 | 9,517 | |||||||
EV/EBITDA | |||||||||
Interest | 1,898 | 2,667 | |||||||
Interest/NOPBT | 25.53% | 31.14% |